Chugai Makes Regenerative Meds Move In Attractive Japan Environment
This article was originally published in PharmAsia News
Executive Summary
Chugai is taking concrete steps into the burgeoning regenerative medicine sector in Japan through a new clinical and commercial alliance with a domestic venture for a therapy for knee cartilage disorders.